R J Biotech financials at a glance
| Year | Year | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
286.81M | 316.68M | 359.59M | 157.38M | 88.87M | 101.16M | 133.83M | 157.96M | 145.71M | 0.00M | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
63.47% | 74.03% | 60.44% | 20.05% | 11.81% | 37.64% | 53.00% | 3.90% | 54.96% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
19.22% | 15.98% | 15.90% | -72.90% | -90.84% | -73.10% | -25.89% | -80.46% | 13.15% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
9.47m | 9.47m | 9.47m | 9.47m | 9.47m | 0m | 9.47m | 9.47m | 9.47m | 9.47m | 0m | 0m |
| OCF | Operating Cash Flow |
|
-51.25M | 24.68M | 57.85M | 0.68M | -26.86M | 8.38M | 7.06M | 19.61M | -51.02M | 0.00M | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
-55.35M | 23.47M | 57.52M | -0.26M | -28.04M | 7.70M | 6.40M | 18.46M | 0.00M | 0.00M | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
-6.71 | 2.48 | 6.08 | -0.03 | -2.96 | 0.81 | 0.68 | 1.95 | -5.39 | 0.00 | 0.00 | 0.00 |